Back to search

Article

Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis

2022-03-12

Abstract excerpt

<h4>ABSTRACT</h4> Millions of praziquantel doses have been delivered in schistosomiasis endemic populations through preventive chemotherapy. However, no comprehensive assessment of short and long-term safety has been conducted. This systematic review assessed safety of praziquantel in persons with and without schistosome infections who received praziquantel treatment. <h4>Methods</h4> We identified relevant stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f049280e-7c08-5d10-8fad-f11ce7bcf49a
DOI
10.1101/2022.03.09.22270839
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysisDOI 10.1101/2022.03.09.22270839
Select a neighboring publication to make it the new centre.